fenofibric acid has been researched along with Retinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourne, PC; Dou, X; Duerfeldt, AS; Ma, JX; Nath, D; Nurmemmedov, E; Shin, H | 1 |
| Chen, Q; Cheng, R; Ding, L; Ma, JX; Moore, R; Moran, E; Takahashi, Y; Wang, Z | 1 |
2 other study(ies) available for fenofibric acid and Retinal Diseases
| Article | Year |
|---|---|
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARĪ± Agonists as Leads for Retinal Disorders.
Topics: Animals; Benzylamines; Capillary Permeability; Cell Line; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Drug Discovery; Humans; PPAR alpha; Rats; Retinal Diseases; Streptozocin | 2020 |
Protective and antioxidant effects of PPARĪ± in the ischemic retina.
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Blotting, Western; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fenofibrate; Glial Fibrillary Acidic Protein; Hypolipidemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Ischemia; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; Nerve Tissue Proteins; Oxidative Stress; Oxygen; PPAR alpha; Reactive Oxygen Species; Retinal Diseases; Retinal Vessels | 2014 |